ST
IRWD icon

Spot Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

Spot Trading’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,746
Closed -$138K – 4496
2014
Q2 		$138K Sell
10,746
-28,059
-72% -$305K ﹤0.01% 3552
2014
Q1 		$400K Buy
38,805
+29,731
+328% +$334K ﹤0.01% 2711
2013
Q4 		$88K Buy
+9,074
New +$81.5K ﹤0.01% 3349

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spot Trading's IRWD Position: Q3 2016 in Review

Spot Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2016, closing a stake of 12 shares.

Spot Trading first reported a position in IRWD in Q3 2013 and held it in 5 quarters. The position peaked at $441K in Q3 2013. 155 funds tracked by Wall St. Rank hold IRWD as of Q3 2016.

  • Spot Trading reported no remaining Ironwood Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Spot Trading sold 12 Ironwood Pharmaceuticals shares in Q3 2016.
  • Spot Trading first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Spot Trading's Ironwood Pharmaceuticals position peaked at $441K in Q3 2013.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2016.

Based on Spot Trading's 13F filing for Q3 2016, filed 31 Oct 2016.